ArticleFrontiers in medicine2026

Real-world effectiveness and safety of tenofovir amibufenamide in treatment-naïve chronic hepatitis B: a 48-week retrospective cohort study.

Jiarui Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.